BioMelbourne Network
Progressing BioIndustry

News and Opinions

Previous1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9

2015

March

MedTech's Got Talent Competition - Applications now Open!

6 March 2015.  Interested in medical technology entrepreneurship? Want $60,000 (plus additional prizes) to get your business or product concept off the ground? Applications for MedTech’s Got Talent are now open, with early bird deadline on 30 March (get feedback and revise your application to be more competitive!) and the final deadline on 8 April.  STC will be holding Medtech’s Got Talent info... read more…
February

Phosphagenics Decides to Sell BioElixia® Cosmetics Brand

25 February 2015.  Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), has put its branded cosmetics division, BioElixia®, up for sale to allow resources to be refocused on the Company’s core areas of strength. Phosphagenics has recently received a number of expressions of interest in purchasing its range of Personal Care products sold under the BioElixia® brand.  ... read more…

Industry Growth Centre Appointments

19 February 2015.   The Minister for Industry and Science, the Hon Ian Macfarlane MP, announced three of the five Chairs of the Industry Growth Centres on the 17 February 2015.   The announced Chairs - Elizabeth Lewis-Gray (METS), Peter Schutz (Food and Agribusiness) and Andrew Stevens (Advanced Manufacturing) - are respected industry leaders with extensive industry expertise and board expe... read more…

Nominations open soon for the 2015 Prime Minister's Prizes for Science

17 February 2015.   Help us recognise Australia’s best scientists and teachers, by nominating them for one of the Prime Minister’s Prizes for Science.   We’re looking for: The heroes of Australian science whose significant contribution to the advancement of knowledge through science deserves recognition; Exceptional innovators from science and industry who have enhanced our economy, ... read more…

BioMelbourne Network Women in Leadership Awards 2015

13 February 2015.  The BioMelbourne Network is very pleased to announce the launch of our inaugural “Women in Leadership” awards, to celebrate, honour and profile outstanding women in the biotechnology, medtech and healthcare technology sector. These new awards are designed to celebrate women who exhibit leadership in their fields of expertise and have made outstanding contributions to advan... read more…

Research Australia Congratulates New NHMRC CEO on Appointment

12 February 2015.  CEO arrives at a time of growth and opportunity in health and medical research.Research Australia welcomes today’s announcement by the Minister for Health, the Hon Sussan Ley, that Professor Anne Kelso AO has been appointed as the new Chief Executive Officer of the National Health and Medical Research Council (NHMRC). Research Australia CEO Elizabeth Foley said the depth of ... read more…

Spinifex Pharmaceuticals Enhances CMC Team with Two Senior Appointments

11 February 2015.  Spinifex Pharmaceuticals, a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has enhanced its Chemistry, Manufacturing & Controls (CMC) capability as it continues to build the management team to drive the development of its lead candidate, EMA401, in a number of chronic pain indications. Dr Peter Spargo has joined Spin... read more…

Otifex - First Phase I Clinical Study Successfully Completed

10 February 2015.  Otifex Therapeutics, an emerging Australian specialty pharmaceutical company developing a new treatment for the most common cause of acquired hearing loss in childhood, Otitis Media with Effusion (OME or ‘glue ear’), has successfully completed the first stage of its clinical development programme. The Phase 1a study, conducted at two clinical sites in Australia, was a random... read more…

Gordagen Expands Corporate and Clinical Expertise as Enters Next Phase of Development

6 February 2015.  Gordagen Pharmaceuticals Pty. Ltd., a private company commercialising natural tocotrienols as evidence-based dietary supplements and pharmaceuticals, is pleased to announce the bolstering of its capacity through the appointment of senior executives and clinical expertise.Under guidance of the Board, Chaired by Mr Fred Nadjarian, former Managing Director of Roche Products, and ... read more…

Sienna Appoints Dr Cliff Holloway as Interim CEO

5 February 2015.  Sienna Cancer Diagnostics Ltd, a Melbourne-based biotechnology company, focused on developing novel in vitro diagnostics tests for cancer, has today announced that Dr Cliff Holloway has been appointed interim Chief Executive Officer. Dr Holloway will replace Dr Kerry Hegarty and commence work on February 2.Dr Holloway brings extensive experience to the role, having held execut... read more…